A Phase 2 placebo controlled, double-blind randomised clinical trial assessing the efficacy of a Herbal supplement for Nocturnal Enuresis in Children
Endeavour College of Natural Health
62 participants
Apr 25, 2018
Interventional
Conditions
Summary
The aim of the study is to determine the effectiveness of a herbal combination capsule (Urox - Bedtime Buddy™), in the treating children aged 6-14 years who experience bed-wetting. It is hypothesised that the combination capsule will reduce the frequency of bed- wetting in children and therefore improve the physical, psycho social and social well being of the child. The trial aims to recruit 62 children in a randomised control trial where the child will receive either the active herbal combination capsule or a placebo. They will take the capsule daily for 8 weeks and record frequency of wet nights in a diary. The parent and child will also complete a validated questionnaire on the impact of bed-wetting on the child quality of life at various time-points in the trial. After the trial is completed follow up phone calls will measure frequency of nocturnal enuresis as well as day time continence questions at 16, 24 and 32 weeks.
Eligibility
Inclusion Criteria3
- Any gender
- Has bed wetting issues equal to or greater than 3 times per week (wet nights)
- Aged: equal to or greater than 6 years old to equal to or less than 14 years old
Exclusion Criteria7
- Vesicoureteral reflux
- Spinal dysraphism
- Recent urotherapy
- Recent or current urinary tract infection (< 1 week)
- Active cancer currently on treatment
- History of cardiac failure
- History of renal dysfunction or urinary retention
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Herbal capsule formulation consisting of; Crateva (Crataeva nurvala) 3000mg Horsetail (Equisetum arvense) 1500mg Lindera (Lindera strychnifolia) 1500mg 1 capsule in the morning (equal to or less than 40kg) or 2 capsules in the morning (greater than 40kg) Duration:8 weeks Monitoring: Participant diary, drug tablet return
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12618000288224